TP53 and neoplasm: TP53 mutations have been documented in a variety of tumor types, including colon (60%), gastric (60%), breast (20%), lung (70%), brain (40%), and esophageal (60%) cancers, with missense mutations in TP53 being the most common (present in an estimated 75% of cases).